
Keywords: تحمل; DSA; donor-specific antibody; HCV; hepatitis C virus; HLA; human leukocyte antigen; IL-6; interleukin 6; ISDT; immunosuppressive drug treatment; LT; liver transplant(ation); NK; natural killer; Non-TOL; non-tolerant; PBMC; peripheral blood mononuclear cel